GE HealthCare Technologies Inc. Common Stock Q2 2025 Earnings Recap

GEHC Q2 2025 July 30, 2025

Get alerts when GEHC reports next quarter

GE HealthCare reported solid second-quarter results, with revenue growth driven by strong orders and strategic partnerships, despite facing tariff-related pressures that impacted margins.

Earnings Per Share Beat

$1.06 vs $0.92 est.

+15.5% surprise

Revenue Beat

5006000000 vs 4973403180 est.

+0.7% surprise

Market Reaction

1-Day -0.45%

5-Day -1.4%

30-Day +3.11%

See GEHC alongside your other holdings

Add to your portfolio — free

Key Takeaways

Revenue of $5 billion with organic growth of 2%, and a significant service revenue increase of 7% year-over-year.
Record backlog of $21.3 billion, up $2.2 billion from the previous year, with a robust book-to-bill ratio of 1.07x.
Adjusted EPS rose 6% year-over-year to $1.06, bolstered by improved tax rates and lower interest expenses.
Strategic collaborations secured, including a $90 million deal with Ascension and a $250 million contract in Europe, enhancing long-term growth prospects.
Free cash flow improved significantly, increasing by $189 million year-over-year to $7 million, attributed to better working capital management.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit GEHC on AllInvestView.

Next Q3 2025